Medical Manufacturing Technologies Acquires Ireland-Based Somex Automation

Medical Manufacturing Technologies, Inc. (MMT), a portfolio company of Arcline Investment Management and a leading global provider of medical device manufacturing solutions, announced the acquisition of Somex Automation (Somex), an Ireland-based provider of custom automation equipment and processes for the medical device manufacturing industry. The Somex product offering will go to market under our MMT Automation brand.

As part of the transaction, Medical Manufacturing Technologies welcomes 34 new employees who will continue to operate out of Somex’s Cork and Ballyvourney facilities in Ireland.

“The acquisition of Somex Automation is a milestone for our company,” said Robbie Atkinson, CEO of Medical Manufacturing Technologies. “We are excited to bring a strong business with highly skilled employees into our family.” Atkinson went on to highlight how the automation and process integration expertise of Somex will become a flagship offering of the MMT Automation brand. “This transaction allows MMT to seamlessly integrate our end-to-end medical device manufacturing to further support our customers on their quest to increase production and expand their ‘lights out’ operation capabilities. The Somex team’s expertise and history of implementation is an asset to our customers.”

“This transaction allows us to grow the bespoke automation and integration solutions offered to medical device manufacturers across the globe,” said Michael Wall, Managing Director and founder of Somex. “We will be able to leverage the strengths of both companies and create an even more powerful offering for our customers.” Wall will join MMT as technical director.

Atkinson stated that MMT launched MMT Automation to streamline its subsidiaries’ automation offerings, further positioning Somex Automation solutions to customers across its portfolio.

“As a global leader of medical device manufacturing equipment and processes, we streamlined shared technologies and processes to ensure our customers have access to the solutions they need when they need them,” said Atkinson. “MMT Automation aligns our automation expertise across the portfolio where we can most effectively help our customers create autonomous manufacturing and continuous optimization of production lines.”

MMT offers its customers a broad portfolio of high-precision solutions for developing and manufacturing complex medical devices used in minimally invasive procedures. Its robust offering expands beyond equipment to proof-of-concept, process development, and TotalCare aftermarket support and services.

Hot this week

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.